Effect of Low Molecular Weight Heparin on Fracture Healing in a Stabilized Rat Femur Fracture Model by Hak, David J. et al.
Effect of Low Molecular Weight Heparin on Fracture Healing 
in a Stabilized Rat Femur Fracture Model 
 
David J. Hak,1 Rena L. Stewart,2 Scott J. Hazelwood1 
 
1Department of Orthopaedic Surgery, University of California, Davis, 4860 Y Street, Suite 3800, Sacramento, California 
95817 
 
2Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, Indiana 
The purpose of this studywas to evaluate the effect of low molecular weight heparin 
(LMWH) on fracture healing in a standard stabilized rat femur fracture model. A closed, 
mid-diaphyseal transverse fracture was created in the right femur of Long-Evans rats after 
insertion of a 0.8-mm K-wire into the medullarycanal. Animals were randomized to receive 
either LMWH (70 units/kg dalteparin) oraninjection of normal saline daily for 2 weeks. 
Animals were sacrificed at 2, 3, and 6 weeks. Fracture healing was assessedbyradiographs, 
histology, and mechanical testing. There were no significant differences between the 
control and LMWH groups in the percentage of animalswith radiographic bridging callus at 
each time point. Histologicappearance of fracture healing was similar between the control 
and LMWH groups. There were no significant differences in the normalized mechanical 
properties of the control and LMWH groups at 2 and 3 weeks. At 6 weeks, the percent 
torque of the LMWH group was significantly greater thanthe control group (p = 0.00 72), 
however, there was no significant difference in the stiffness and energy absorption. 
Dalteparin, at the dosage used in this study, did not impair fracture healing in this standard 
stabilized rat femur fracture model. 
INTRODUCTION 
Despite common usage, little is known about the effect of low molecular weight 
heparin (LMWH) on fracture healing. Street and colleagues have reported a significant 
delay in fracture healing following the administration of LMWH in an unstabilized rabbit 
rib fracture model.1 Both standard heparin and LMWH have been shown to have 
deleterious effects on bone, causing osteoporo-sis, stimulating bone resorption, increasing 
calcium loss, and decreasing bone turnover.2–9 Concern has also been raised that the 
impairment of bone formation by heparin may adversely effect integra-tion of porous 
ingrowth prostheses. 10 
Thromboembolic complications are the most common preventable cause of 
mortality and mor-bidity in the trauma patient.11–17 For this reason, the vast majority of 
trauma patients with orthope-dic injuries receive some form of thromboembolism 
prophylaxis, eitherbymechanical or pharmacolo-gical means, or both. Decisions regardling 
throm-boembolism prophylaxis often requires physicians to weigh complex risks and 
benefits of different treatment options. A recent meta-analysis compared the efficacy 
ofheparin, warfarin, and LMWH and found LMWH to be superior in preventing 
thromboembolism.18 LMWH is easily administered and requires little or no laboratory 
monitoring.19 Therefore, LMWH has become a popular method of thromboembolism 
prophylaxis in the trauma patient. Because large numbers of trauma patients with lower 
extremity and pelvic fractures routinely receive LMWH prophylactically, it is imperative to 
consider whether LMWH may have an adverse impact on fracture healing. 
METHODS 
Male Long-Evans rats, with a mean age of 13 weeks (range, 12–15weeks) and a 
mean bodyweight of 391 g (range, 346–434 g), were used. The study protocol was 
approved by the local Institutional Animal Care and Use Committee, and all animal 
experimentation was carried out with adherence to NIH and the Committee guide-lines. All 
surgical procedures were performed under sterile operating conditions with the rats under 
general anesthesia (4% halothane inhalation followed by intra-peritoneal injection of 80 
mg/kg ketamine hydrochloride and 8 mg/kg xylazine hydrochloride). A 1-cm lateral 
parapatellar incision was made and the patella displaced laterally to expose the distal 
femoral condyle of the right hind limb. A 0.8-mm diameter K-wire (Synthes, Paoli, PA) was 
inserted into the femoral canal in a retrograde fashion starting from the trochlear groove 
and advan-cing proximally through the greater trochanter until the distal end was flush 
with the femoral condyle. A small incision was then made over the greater trochanter and 
the K-wire was cut flush with the proximal end of the femur. The wounds were then 
irrigated and closed using 4.0 nylon suture. A closed, transverse, mid-shaft fracture was 
then created in the pinned femur using a three-point bending apparatus with a drop weight 
as describedbyBonnarens and Einhorn.20 
Radiographs were taken immediately postoperatively to verifyproper intramedullary 
wire placement and fracture configuration. Any rats with comminuted frac-tures were 
excluded from the study. Animals were permitted full weight bearing and unrestricted 
movement upon awakening from anesthesia. Postoperative pain was controlled using a 
peritoneal injection of 0.05 mg/kg buprenorphine hydrochloride initially and oral 
buprenor-phine suspended ingelatin twice daily for 2 days. 
The animals were randomized to either the LMWH group, receiving 70 units/kg 
dalteparin sodium (Fragmin, Pfizer, New York,NY), or to the control group, receiving 
thesame volume of normalsaline. The subcutaneous injections were administered once 
daily to alternate sites of the anterior abdominal wall for 14 days beginning on 
postoperative day 1. Animals were maintained for intervals of 2, 3, and 6 weeks. 
Euthanization was carried out with inhalation of carbon dioxide gas. 
Radiologic Evaluation 
Standardized radiographs (Faxitron, Wheeling, IL) were performed using constant settings 
with the animal anesthetized and positioned pronewith both hind limbs fully abducted. 
They were obtained immediately post-operatively to confirm satisfactory fracture 
configuration and proper K-wire position. Similar radiographs were taken at the time of 
sacrifice, and fracture union was evaluatedbytwo, blinded, independent observers. Frac-
ture union was defined as the presence of bridging callus alongopposite cortices. In five 
cases when the reviewers differed in their interpretation, the classification of healed 
versus not healed was madebyconsensus agreement. 
Histological Evaluation 
Four animals from each group and time point were randomly selected for 
histological analysis. The frac-tured femur was harvested and fixed in 4% paraforma-
ledhyde in 0.1 M phosphate buffer for 24 h at 48C, and then defatted in methanol, 
decalcified with 10% formic acid in citrate for 4 days, and embedded in paraffin. All 
specimens had adequate soft callus to maintain the position of the proximal and distal 
fragments. Speci-mens were sectioned longitudinally in 4-tm sections and stained with 
hematoxolin and eosin. The degree of fracture healing was evaluated using a five-point 
qualitative scale proposedbyAllen et al.21 According to this classification system, grade 4 
represents com-plete bony union, grade 3 represents an incomplete bony union (presence 
of a small amount of cartilage in the callus), grade 2 represents a complete cartilaginous 
union (well-formed plate of hyaline cartilage uniting the fragments), grade 1 represents an 
incomplete cartilagi-nous union (retention of fibrous elements in the cartilaginous plate), 
and grade 0 indicates the formation of a pseudoarthrosis (most severe form of arrest in 
fracture repair). 
Mechanical Evaluation 
The remaining specimens were subjected to mechanical testing. Following 
euthanasia, both the fractured femur and the intact femur on the contralateral side were 
dissected free of surrounding soft tissue and the intramedullary K-wire was removed. 
Sufficient soft callus was present in all specimens to maintain the relationship between 
the proximal and distal fragments. The specimens were centered in two colinerally 
positioned cylindrical pots and imbedded in Wood’s metal (Alfa Aesar, Ward Hill, MA). 
The distal end of the femur was first positionedbycentering the long axis of the bone and 
securing it with Wood’s metal. A custom jig was then used to position the proximal end 
of the femur for imbedding in the second cylindrical pot. The speci-mens were then 
mounted in a Frankel-Bursteinaxial torsion machine modified to operate under 
computer control.22 The standard swinging-pendulum mechanism was replaced with a 
stepper motor (model 083062-1-8- 031-010, Parker Compumotor, Rohnert Park, CA). 
Rotational displacement was measured with a precision potentiometer (model 793341-
14092, Gould Instrument Division, Cleveland, OH), and torque was measured with a 0.7 
Nm torque cell (model 2105, Eaton Corpora-tion, Troy, MI). Specimens were tested in 
torsion at a rate of 50 degrees per minute through an arc of 45 degrees. Rotational 
displacement and torque data were collected at 60 Hertz using a digital data acquisition 
system (model K500A, Keithley Instruments, Cleveland, OH). Maximum torque to failure 
was measured directly from the data, and the torsional stiffness was calculated from the 
regression of the linear portion of the torque versus the angular displacement curve. 
The energy absorption to maximum torque was calculated as the area under the curve to 
the maximum value. All biomechanical measurements were repeated on the intact, 
contralateral femur in an identical manner. For each animal, the stiffness, maximum 
torque to failure, and energy absorption to maximum torque were each calculated as a 
percentage of the intact femur to allow for accurate comparison between animals. 
Statistical Analysis 
A two-factor analysis of variance (ANOVA) was performed on the normalized data of 
the biomechanical properties to account for individual animal differences. The factors were 
the time point (2, 3, and 6 weeks) and the experimental group (control or LMWH). 
Significance was defined as p values less than 0.05. When appro-priate, a Bonferroni-Dunn 
post hoc test was performed to determine differences between the factors at each time 
point. 
RESULTS 
Nine animals were excluded from the study. One animal died of unknown causes on 
postoperative day 1, and four others died of anesthetic complica-tions while undergoing 
radiographs. Four other animals were excluded because the the initial postoperative 
radiograph showed fracture comminution. No clinical evidence of infection was noted in 
any animals during this study. 
 Radiologic Evaluation  
A varying degree of callus was seen at 2 weeks, but none of the fractures showed 
clear evidence of bridging callus in either the control (Fig. 1A) or LMWH group (Fig. 1D). 
At 3 weeks, one-third (4/12) of the control group (Fig. 1B) and one-third (4/12) of the 
LMWH group (Fig. 1E) showed clear evidence of bridging callus on opposite cortices. At 6 
weeks, 62% (8/13) of control group (Fig. 1C) and 67% (8/12) of LMWH group (Fig. 1F) 
showed clear evidence of bridging callus on opposite cortices. 
Histological Evaluation 
Two weeks following fracture, both control (Fig. 2A) and LMWH (Fig. 2D) 
specimens had abundant callus formation. Newly formed woven bone (intramembranous 
ossification) surrounded the fracture peripherally, while abundant nonbrid-ging 
chondrocytes were present centrally. At 3 weeks, there was increased evidence of endo-
chondral ossification in both the control (Fig. 2B) and LMWH (Fig. 2E) specimens. 
Chondrocyte areas were smaller, and some specimens showed evidence of partial bone 
bridging. At 6 weeks, there was further evidence of fracture healing in both the control 
(Fig.2C) and LMWH (Fig. 2F) specimens, with complete replacement of chondrocytesby 
bridging bone in most specimens. 
Histological grading of the fracture healing was similar between the control and 
LMWH groups. At 2 weeks, all specimens in both groups were graded 2. At 3 weeks, the 
fracture healing grade ranged from 2 to 3, with the mean being 2.5 in both groups. At 6 
weeks, the fracture healing grade ranged from 3 to 4, with a control group mean of 3.5 and 
LMWH group mean of 3.75. 
Mechanical Testing 
The means and standard deviations of the max-imum torque to failure, stiffness, 
and energy absorption to maximum torque are shown in Table 1. The maximum torque 
and stiffness of the control group fractured femurs increased between each time point, 
with the mean maximum torque and the mean stiffnessapproaching that of the intact 
femurs at 6 weeks. In the LMWH group, there was a less dramatic increase between 2 and 
3 weeks, butby6 weeks the mean maximum torque and mean stiffness also approached 
that of the intact femurs. A post hoc power analysis of the mechanical data was performed. 
The power for the maximum torque and stiffness was >0.9, while the power for energy 
was 0.42. 
To account for variation in animal size, the maximum torque, stiffness, and energy 
absorption values were normalizedbythe respective values of the contralateral intact 
femurs. The mean and standard deviations of the percent maximum torque, percent 
stiffness, and percent energy were calculated for each group (Fig. 3). There were no 
significant differences in the normalized mechan-ical properties of the control and LMWH 
groups at 2 and 3 weeks. At 6 weeks, the percent torque of the LMWH group 
(0.864士0.288) was significantly greater (p=0.0072) than the control group 
(0.609士0.165), however, there was no significant difference in the stiffness and energy 
absorption. 
DISCUSSION 
Street et al. reported a significant delay in fracture healing following the 
administration of enoxaparin in an unstabilized rabbit rib fracture model.1 Fracture 
healing was assesed by histology, histo-morphometry, and immunohistochemistry at 
days 3, 7, and 14, and by mechanical testing at 21 days following fracture. At days 3, 7, 
and 14, they found fewer proliferating cells and fewer transforming pericytes in the 
medullary callus of the enoxaparin-treated rabbits. In the enoxaparin group, the 
histologic grade of fracture healing was reduced at days 7 and 14, and the mechanical 
properties were weaker at day 21 compared to the control animals. Because of Street 
and coworkers’ finding that low molecular weight heparin impaired fracture healing, we 
investigated the use of dalteparin in a standard stabilized rat femur fracture model. In 
contrast to the findings of Street et al., in the current studywe found that administration 
of LMWH did not have any deleterious effect on fracture healing mechanical properties. 
Other previous reports have also described deleterious effects of anticoagulants, in 
particular heparin, on bone repair. In 1956, Stinchfield et al. demonstrated that daily 
administration of standard heparin or warfarin significantly impaired fracture repair in 
rabbit and canine models.9 Several studies have also identified the long-term use of 
heparin as a risk factor for the development of osteoporosis in humans.2,4,5,7,8 Chowdhury 
et al. concluded that low doses of standard heparin directly stimulated bone resorption by 
increasing the number of differentiated osteoclasts and by enhancing the activitiy of 
individual osteoclasts.3 
Several studies have suggested that LMWH may have less deleterious effects on 
bone homeostasis. In fetal rat calvaria culture, LMWH produced significantly less calcium 
loss than heparin.23 Matzsch et al. demonstrated that LMWH stimulated bone resorption to 
a lesser degree than did heparin, although overall density decreased to a similar extent 
with both agents.7 In a study comparing 28 days of injection of either heparin or a LMWH 
(dalteparin), the rats treated with standard heparin showed a significant reduction in 
osteoid surface and mineral appostion rates, and seven of eight rats suffered spontaneous 
femoral fractures. In contrast, the rats treated with the LMWH showed minimal decreases 
in bone indices and no fractures.24 Variable effects have been shown with different LMWH 
formulations. In one study,fondaparinux was shown to have higher mitochondrial activity 
and protein synthesis in osteoblasts compared to enoxaparin and unfractio-nated 
heparin.10 While LMWH maynot produce osteoporosis to the same extent as standard 
heparin, concern remains regarding the effect of LMWH on bone healing. At 
supertherapeutic doses, LMWH has been shown to decrease cancel-lous bone volume as 
demonstrated by a lack of normal remodeling and repair in an in vitro bone nodule 
assay.25 Supertherapeutic doses have also been shown to decrease the osteoid surface 
area and to decrease alkaline phosphatase activity in a dose-dependent manner.26 
Because LMWH has a faster onset of action compared to warfarin, it is not 
surprising that a higher rate of surgical site hematomas has been observed with the use of 
LMWH in total hip arthroplasty.27 The early use of LMWH in patients with fractures may 
preumably lead to a larger fracture site hematoma. It is generally accepted that fracture 
site hematoma plays a beneficial role in fracture healing. Mizuno et al. has shown that 
fracture site hematoma has osteogenic potential.28 Several studies have shown that 
evacuation of this hematoma can be deleterious on fracture healing, especially when 
performed several days following fracture after the inflammatory phase has ended.29,30 In 
contrast, Street et al. has shown that the high potassium concentration of fracture site 
hematoma is cytotoxic to endothelial cells and osteoblasts.31 Only after these cytotoxic 
elements undergo resporption can the angiogenic and osteo-genic cytokines present in 
fracture hematoma function. Brighton and Hunt have described an area of architectural 
disruption and cell degrada-tion that diminishes with the distance from the hematoma.32 
Therefore, increased fracture site hematoma volume may have deleterious effects of 
fracture healing. Whereas in this studywe were unable toquantifyfracture hematoma 
volume, we did not observe any detrimental impact of short term administration of 
LMWH on fracture healing. 
This studyhas anumber of limitations. Since the optimal duration of prophylaxis 
following trauma is undefined, we arbitrarily chose 14 days of LMWH administration to 
model its short term prophylactic use following pelvic or lower extremity trauma. We 
did not perform a dose-response study examining higher doses of dalteparin. The dose 
of dalteparin used in this study was based on the standard human dose and adjusted for 
animal weight. However, because of differences in metabolism, a higher dose may be 
required to obtain equivalent antithrombotic efficacy.33 The standard prophylac-tic 
dose of dalteparin is 5,000 units daily, which for a 70-kg adult is approximately 70 
units/kg. In comparison, Street et al., using a rabbit model, selected a daily enoxaparin 
dose of 2 mg, which based on animal weight was roughly 1 mg/kg. That dose is 
somewhat greater than the standard daily prophylactic enoxaparin dose of 40 mg, 
which equates to 0.57 mg/kg for a standard 70-kg adult. We did not evaluate any 
coagulation parameters during the study to determine what effect, if any, the 
administered dose of dalteparin was having on the animals coagulation system. We 
were also unable to quantifythe size of fracture site hema-toma to determine whether 
this was effected by the administration of dalteparin. While we examined the histology 
qualitatively, we did not perform a quantitative histomophometric analysis of the 
fracture callus. In the prior study,in which LMWH was found to delay fracture repair, 
enoxaparin was used, whereas in this investigation, we used dalteparin.1 While low 
molecular weight heparins have a similar mechanism of action, minor varia-tions 
between the different available products could affect their impact on fracture healing. 
Finally, there is no evidence that our standard rat femur fracture model offers any 
applicability to human fracture healing. 
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